vs
Side-by-side financial comparison of Atour Lifestyle Holdings Ltd (ATAT) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Atour Lifestyle Holdings Ltd is the larger business by last-quarter revenue ($789.6M vs $397.6M, roughly 2.0× Guardian Pharmacy Services, Inc.). Atour Lifestyle Holdings Ltd runs the higher net margin — 17.6% vs 5.3%, a 12.4% gap on every dollar of revenue.
Atour Lifestyle Holdings Ltd is a leading China-based hospitality and lifestyle enterprise. It operates a wide portfolio of mid-to-premium hotel brands for business and leisure travelers, and offers complementary lifestyle retail products and experience services, catering primarily to middle-class consumers across domestic and selected overseas markets.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
ATAT vs GRDN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $789.6M | $397.6M |
| Net Profit | $139.1M | $20.9M |
| Gross Margin | — | 21.5% |
| Operating Margin | 22.5% | 7.7% |
| Net Margin | 17.6% | 5.3% |
| Revenue YoY | 252.5% | — |
| Net Profit YoY | 322.2% | — |
| EPS (diluted) | $0.33 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $397.6M | ||
| Q3 25 | $789.6M | $377.4M | ||
| Q2 25 | — | $344.3M | ||
| Q1 25 | — | $329.3M | ||
| Q3 24 | $224.0M | $314.4M | ||
| Q1 24 | $203.4M | — | ||
| Q1 23 | $106.8M | — |
| Q4 25 | — | $20.9M | ||
| Q3 25 | $139.1M | $9.8M | ||
| Q2 25 | — | $9.0M | ||
| Q1 25 | — | $9.4M | ||
| Q3 24 | $33.0M | $-122.0M | ||
| Q1 24 | $35.6M | — | ||
| Q1 23 | $2.5M | — |
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 19.5% | ||
| Q3 24 | — | 19.4% | ||
| Q1 24 | — | — | ||
| Q1 23 | — | — |
| Q4 25 | — | 7.7% | ||
| Q3 25 | 22.5% | 4.3% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 3.9% | ||
| Q3 24 | 14.7% | -33.3% | ||
| Q1 24 | 22.1% | — | ||
| Q1 23 | 8.0% | — |
| Q4 25 | — | 5.3% | ||
| Q3 25 | 17.6% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.9% | ||
| Q3 24 | 14.7% | -38.8% | ||
| Q1 24 | 17.5% | — | ||
| Q1 23 | 2.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | $0.33 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $0.08 | — | ||
| Q1 24 | $0.09 | — | ||
| Q1 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $669.2M | $65.6M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | $405.0M | $217.9M |
| Total Assets | $1.1B | $412.7M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $65.6M | ||
| Q3 25 | $669.2M | $36.5M | ||
| Q2 25 | — | $18.8M | ||
| Q1 25 | — | $14.0M | ||
| Q3 24 | $506.0M | $37.2M | ||
| Q1 24 | $520.7M | — | ||
| Q1 23 | $272.5M | — |
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $34.3M | ||
| Q1 24 | $277.0K | — | ||
| Q1 23 | — | — |
| Q4 25 | — | $217.9M | ||
| Q3 25 | $405.0M | $195.5M | ||
| Q2 25 | — | $179.7M | ||
| Q1 25 | — | $163.2M | ||
| Q3 24 | $291.3M | $133.9M | ||
| Q1 24 | $323.5M | — | ||
| Q1 23 | $185.5M | — |
| Q4 25 | — | $412.7M | ||
| Q3 25 | $1.1B | $390.0M | ||
| Q2 25 | — | $356.3M | ||
| Q1 25 | — | $334.0M | ||
| Q3 24 | $927.8M | $348.0M | ||
| Q1 24 | $936.3M | — | ||
| Q1 23 | — | — |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.26× | ||
| Q1 24 | 0.00× | — | ||
| Q1 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $216.6M | $34.6M |
| Free Cash FlowOCF − Capex | $210.7M | — |
| FCF MarginFCF / Revenue | 26.7% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | 1.56× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $359.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $34.6M | ||
| Q3 25 | $216.6M | $28.2M | ||
| Q2 25 | — | $19.9M | ||
| Q1 25 | — | $17.6M | ||
| Q3 24 | $84.8M | — | ||
| Q1 24 | $19.8M | — | ||
| Q1 23 | $49.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | $210.7M | $24.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $83.3M | — | ||
| Q1 24 | $18.1M | — | ||
| Q1 23 | $47.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | 26.7% | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 37.2% | — | ||
| Q1 24 | 8.9% | — | ||
| Q1 23 | 44.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.7% | — | ||
| Q1 24 | 0.9% | — | ||
| Q1 23 | 2.3% | — |
| Q4 25 | — | 1.65× | ||
| Q3 25 | 1.56× | 2.87× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.86× | ||
| Q3 24 | 2.57× | — | ||
| Q1 24 | 0.56× | — | ||
| Q1 23 | 20.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
